Ranbaxy fails to answer the FDA's questions on manufacturing

02/4/2010 | Economic Times (India), The

Ranbaxy Laboratories failed to address the FDA's concerns regarding its manufacturing practices at facilities that produce drugs exported to the U.S., according to a warning letter from the agency. The FDA said it "expects Ranbaxy to immediately undertake a comprehensive assessment of its global manufacturing operations to ensure that all sites manufacturing drug[s] for the U.S. market conform to U.S. requirements."

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN